
Opinion|Videos|March 31, 2026
Recognizing Demodex Blepharitis: Prevalence, Diagnosis, and Clinical Impact
Prof. Nanavaty outlines Demodex blepharitis, highlights colorette counts as a measure of severity, and emphasizes that despite its high prevalence in patients, it is frequently overlooked and should be routinely assessed during eye exams.
Advertisement
Episodes in this series
Prof. Nanavaty defines Demodex blepharitis and explains how colorette counts are used to categorize severity. He shares findings from his UK study showing that nearly 60% of routine ophthalmology patients had at least one colorette and approximately 25% had moderate-to-severe disease. He discusses the case for making colorette assessment a routine part of slit-lamp exams, and addresses why the condition remains underdiagnosed and frequently misattributed to generic blepharitis.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Eye Care Network - Ophthalmology Times
1
AAO 2026: DAYBREAK shows tarcocimab and tabirafusp-ted noninferior to aflibercept in wet AMD
2
AAO 2026: Optogenetic gene therapy heads to phase 2 trial in geographic atrophy
3
Slowing Stargardt: What a 36% reduction in lesion growth could mean for adolescent patients
4
AAO 2026: Blood pressure and optic nerve perfusion: a complex relationship
5






















